Defining the Future of Bacterial Glycoconjugate Vaccines

Engineering Durable Immunity Through Rational Innate Immune Design

 

The Turbo Platform is a proprietary immunological technology that integrates defined innate immune costimulation into bacterial glycoconjugate vaccines to improve durability, consistency, and long-term protection.

 

​

 

​

THE CHALLENGE

Today's Glycoconjugate Vaccines Solve Only Half of the Immunology Problem

 

Protein conjugation revolutionized bacterial vaccine development by converting poorly immunogenic polysaccharides into T cell-dependent antigens.However, while adaptive immunity is well defined, the innate immune signals that initiate and shape durable protective immunity remain largely undefined.This represents one of the last major opportunities to improve bacterial glycoconjugate vaccine design.

​​

​​​

​

OUR SOLUTION​

A Platform for Defined Innate Immune Design

 

Turbo is a proprietary platform technology that replaces variable innate immune activation with a rational, reproducible immunological approach.

 

By integrating defined innate costimulation into glycoconjugate vaccines, Turbo is designed to:

• Improve durability of protective immunity

• Reduce dependence on multiple booster immunizations

• Enhance consistency across vaccine formulations

• Enable next-generation bacterial vaccine development

​​​

​

​

WHY TURBOVAX?

​

Scientifically Validated

​

Mechanistically defined through peer-reviewed immunological research.

 

​

Platform Technology

​

Applicable across multiple bacterial glycoconjugate vaccine programs.

 

​

Partnership Ready

​

Designed for strategic partnerships with vaccine manufacturers

rather than competing with them.

​

 

​​

​

OUR VISION

​

We believe the next generation of bacterial glycoconjugate vaccines will combine adaptive immunity with rational innate immune design.

 

TurboVax is building that future.

 

​

 

FEATURED HIGHLIGHTS

​

✓ Peer-reviewed scientific publications

✓ Strong intellectual property portfolio

✓ International Scientific Advisory Board

✓ Platform applicable across multiple bacterial vaccine programs

​

 

​

CALL TO ACTION

​

Building the Next Generation of Bacterial Vaccines Together

​

TurboVax welcomes discussions with strategic partners, investors, and collaborators who share our vision for advancing bacterial vaccine innovation.​​​​

​